Unknown

Dataset Information

0

Deletions of immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia.


ABSTRACT:

Background

Chronic myelogenous leukemia (CML) results from the neoplastic transformation of a haematopoietic stem cell. The hallmark genetic abnormality of CML is a chimeric BCR/ABL1 fusion gene resulting from the Philadelphia chromosome rearrangement t(9;22)(q34;q11). Clinical and laboratory studies indicate that the BCR/ABL1 fusion protein is essential for initiation, maintenance and progression of CML, yet the event(s) driving the transformation from chronic phase to blast phase are poorly understood.

Results

Here we report multiple genome aberrations in a collection of 78 CML and 14 control samples by oligonucleotide array comparative genomic hybridization. We found a unique signature of genome deletions within the immunoglobulin heavy chain (IGH) and T cell receptor regions (TCR), frequently accompanied by concomitant loss of sequences within the short arm regions of chromosomes 7 and 9, including IKZF1, HOXA7, CDKN2A/2B, MLLT3, IFNA/B, RNF38, PAX5, JMJD2C and PDCD1LG2 genes.

Conclusions

None of these genome losses were detected in any of the CML samples with myeloid transformation, chronic phase or controls, indicating that their presence is obligatory for the development of a malignant clone with a lymphoid phenotype. Notably, the coincidental deletions at IGH and TCR regions appear to precede the loss of IKZF1 and/or p16 genes in CML indicating a possible involvement of RAG in these deletions.

SUBMITTER: Nacheva EP 

PROVIDER: S-EPMC2822760 | biostudies-literature | 2010 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Deletions of immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia.

Nacheva Elisabeth P EP   Brazma Diana D   Virgili Anna A   Howard-Reeves Julie J   Chanalaris Anastasios A   Gancheva Katya K   Apostolova Margarita M   Valgañon Mikel M   Mazzullo Helen H   Grace Colin C  

BMC genomics 20100118


<h4>Background</h4>Chronic myelogenous leukemia (CML) results from the neoplastic transformation of a haematopoietic stem cell. The hallmark genetic abnormality of CML is a chimeric BCR/ABL1 fusion gene resulting from the Philadelphia chromosome rearrangement t(9;22)(q34;q11). Clinical and laboratory studies indicate that the BCR/ABL1 fusion protein is essential for initiation, maintenance and progression of CML, yet the event(s) driving the transformation from chronic phase to blast phase are p  ...[more]

Similar Datasets

| S-EPMC19472 | biostudies-literature
| S-EPMC7261178 | biostudies-literature
2018-12-21 | GSE113938 | GEO
2013-06-01 | GSE47129 | GEO
2013-06-01 | E-GEOD-47129 | biostudies-arrayexpress
| S-EPMC2435157 | biostudies-literature
| S-EPMC2268805 | biostudies-other
| S-EPMC6262782 | biostudies-literature
2013-07-16 | GSE48870 | GEO
2013-07-16 | E-GEOD-48870 | biostudies-arrayexpress